COVID‐19 vaccines tolerated in patients with paclitaxel and docetaxel allergy
Aleena Banerji, Anna R. Wolfson, Lacey B. Robinson, Aubree E. McMahon, Amelia S. Cogan, Rebecca R. Saff, Kimberly G. Blumenthal
Abstract
Dr. Blumenthal receives grant support from the NIH/NIAID K01 AI12563 and the Massachusetts General Hospital Department of Medicine Transformative Scholar Program.
Topics & Concepts
DocetaxelCoronavirus disease 2019 (COVID-19)MedicinePaclitaxelAllergy2019-20 coronavirus outbreakFamily medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineVirologyImmunologyChemotherapyDiseaseInfectious disease (medical specialty)OutbreakDrug-Induced Adverse ReactionsAllergic Rhinitis and SensitizationSARS-CoV-2 and COVID-19 Research